Hypertension is known to increase the risk of atrial fibrillation. It has a role 
to play in atrial fibrosis and remodeling which tends to propagate further 
atrial fibrillation. Current anti arrhythmic therapy is unsatisfactory due to 
its toxicity. Management of hypertension offers an attractive target for 
improving therapy of atrial fibrillation. We examine the current evidence for 
anti hypertensive therapy in atrial fibrillation.